Metabolic syndrome may participate in the carcinogenesis of CRC through several mechanisms: i) insulin resistance, which leads to the accumulation of reactive oxygen species (ROS) and results in DNA damage and mutation; ii) increasing levels of leptin and adipokines promote the occurrence of CRC (83). Here, LEP is linked to colorectal carcinoma.